Business
Anti-inflammatory drug may shorten COVID-19 recovery time – Sydney Morning Herald
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their time to recovery by an additional day.
Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalised COVID-19 patients.
It would be important to know how many study participants also received steroid drugs, which have been shown in other research to lower the risk of death for severely ill, hospitalised COVID-19 patients, said Dr Jesse Goodman, former US Food and Drug Administration chief scientist now at Georgetown University who had no role in the study.
Figuring out how to best use t…
-
Noosa News20 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News7 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News21 hours agoFarmgate Backpackers leads with integrity amid industry challenges
-
General15 hours agoWall St futures bounce, Asia still shaky